Orthofix Medical Inc (FRA:OM2) Stock Price, Trades & News

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	0.44
Equity-to-Asset	0.49
Debt-to-Equity	0.55
Debt-to-EBITDA	12.36
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	1.1	Distress Grey Safe
Beneish M-Score	-2.87	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

2/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	-3.3
	3-Year EBITDA Growth Rate	-31.5
	3-Year FCF Growth Rate	73.6
	3-Year Book Growth Rate	-12.2
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	29.05
	Future 3-5Y Total Revenue Growth Rate Estimate	3.81

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	47.46
	9-Day RSI	42.84
	14-Day RSI	44.33
	3-1 Month Momentum %	-3.43
	6-1 Month Momentum %	-14.35
	12-1 Month Momentum %	-19.26

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.84
	Quick Ratio	1.67
	Cash Ratio	0.66
	Days Inventory	269.21
	Days Sales Outstanding	58.68
	Days Payable	83.11

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-25.5
	Shareholder Yield %	-11.49

Profitability Rank

3/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	71.31
	Operating Margin %	-4.47
	Net Margin %	-7.41
	EBITDA Margin %	2.28
	FCF Margin %	-3.4
	OCF Margin %	1.9
	ROE %	-13.93
	ROA %	-7.21
	ROIC %	-5.37
	3-Year ROIIC %	-19.19
	ROC (Joel Greenblatt) %	-12.24
	ROCE %	-5.67
	Years of Profitability over Past 10-Year	4
	Moat Score	4
	Tariff Resilience Score	6

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	67.01
	PS Ratio	0.48
	PB Ratio	0.95
	Price-to-Tangible-Book	2.42
	Price-to-Operating-Cash-Flow	24
	EV-to-EBIT	-13.63
	EV-to-EBITDA	28.37
	EV-to-Forward-EBITDA	11.99
	EV-to-Revenue	0.65
	EV-to-Forward-Revenue	0.63
	EV-to-FCF	-19.36
	Price-to-GF-Value	0.72
	Price-to-Projected-FCF	3.64
	Price-to-Median-PS-Value	0.35
	Price-to-Net-Current-Asset-Value	174
	Earnings Yield (Greenblatt) %	-7.34
	FCF Yield %	-6.82
	Forward Rate of Return (Yacktman) %	26.51

Financials (Next Earnings Date:2026-11-04 Est.)

Annual Quarterly TTM

FRA:OM2's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Orthofix Medical Inc Executives

Details

GF Value™: €12.11

FRA:OM2

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 5 Severe warning signs with OM2. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	716.246
	EPS (TTM) (€)	-1.326
	Beta	1.4256
	3-Year Sharpe Ratio	-0.2
	3-Year Sortino Ratio	-0.27
	Volatility %	47.12
	14-Day RSI	44.33
	14-Day ATR (€)	0.259374
	20-Day SMA (€)	9.2825
	12-1 Month Momentum %	-19.26
	52-Week Range (€)	7.55 - 13.7
	Shares Outstanding (Mil)	40.73

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Orthofix Medical Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Orthofix Medical Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-04 08:30	In 76 days
Third quarter earnings results for 2026	2026-11-04	In 75 days
Canaccord Genuity’s 46th Annual Growth Conference	2026-08-12 09:30	8.60 (+0.00%)
Needham Virtual MedTech & Diagnostics 1x1 Conference	2026-08-10	8.90 (+0.00%)
Second quarter earnings conference call for 2026	2026-08-05 08:30	10.40 (+0.00%)
Second quarter earnings results for 2026	2026-08-05	10.40 (+0.00%)
General meeting for 2026	2026-06-10 08:00	8.15 (+0.00%)
First quarter earnings conference call for 2026	2026-05-05 08:30	9.85 (+0.00%)
First quarter earnings results for 2026	2026-05-05	9.85 (+0.00%)
TD Cowen 46th Annual Health Care Conference	2026-03-03 11:10	11.30 (+0.00%)

Show

Entries

Orthofix Medical Inc Frequently Asked Questions

What is Orthofix Medical Inc(FRA:OM2)'s stock price today?

The current price of FRA:OM2 is €8.70. The 52 week high of FRA:OM2 is €13.70 and 52 week low is €7.55.

When is next earnings date of Orthofix Medical Inc(FRA:OM2)?

The next earnings date of Orthofix Medical Inc(FRA:OM2) is 2026-11-04 Est..

Does Orthofix Medical Inc(FRA:OM2) pay dividends? If so, how much?

Orthofix Medical Inc(FRA:OM2) does not pay dividend.

Press Release

	Subject	Date
	Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress	2026-08-05
	Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?	2026-07-29
	MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth	2026-07-21
	Orthofix to Participate in Upcoming Investor Conferences	2026-07-20
	Orthofix to Report Second Quarter 2026 Financial Results	2026-07-15
	Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?	2026-06-05
	SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)	2026-05-26
	Orthofix to Participate in Upcoming Investor Conferences	2026-05-18
	Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX	2026-04-24
	Orthofix to Report First Quarter 2026 Financial Results	2026-04-21

10/Page

Articles on Orthofix Medical Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.